Cargando…
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consiste...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674735/ https://www.ncbi.nlm.nih.gov/pubmed/29110676 http://dx.doi.org/10.1186/s12987-017-0079-9 |
_version_ | 1783276838211026944 |
---|---|
author | Greenwood, John Hammarlund-Udenaes, Margareta Jones, Hazel C. Stitt, Alan W. Vandenbrouke, Roosmarijn E. Romero, Ignacio A. Campbell, Matthew Fricker, Gert Brodin, Birger Manninga, Heiko Gaillard, Pieter J. Schwaninger, Markus Webster, Carl Wicher, Krzysztof B. Khrestchatisky, Michel |
author_facet | Greenwood, John Hammarlund-Udenaes, Margareta Jones, Hazel C. Stitt, Alan W. Vandenbrouke, Roosmarijn E. Romero, Ignacio A. Campbell, Matthew Fricker, Gert Brodin, Birger Manninga, Heiko Gaillard, Pieter J. Schwaninger, Markus Webster, Carl Wicher, Krzysztof B. Khrestchatisky, Michel |
author_sort | Greenwood, John |
collection | PubMed |
description | This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers. |
format | Online Article Text |
id | pubmed-5674735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56747352017-11-15 Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 Greenwood, John Hammarlund-Udenaes, Margareta Jones, Hazel C. Stitt, Alan W. Vandenbrouke, Roosmarijn E. Romero, Ignacio A. Campbell, Matthew Fricker, Gert Brodin, Birger Manninga, Heiko Gaillard, Pieter J. Schwaninger, Markus Webster, Carl Wicher, Krzysztof B. Khrestchatisky, Michel Fluids Barriers CNS Review This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers. BioMed Central 2017-11-07 /pmc/articles/PMC5674735/ /pubmed/29110676 http://dx.doi.org/10.1186/s12987-017-0079-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Greenwood, John Hammarlund-Udenaes, Margareta Jones, Hazel C. Stitt, Alan W. Vandenbrouke, Roosmarijn E. Romero, Ignacio A. Campbell, Matthew Fricker, Gert Brodin, Birger Manninga, Heiko Gaillard, Pieter J. Schwaninger, Markus Webster, Carl Wicher, Krzysztof B. Khrestchatisky, Michel Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title | Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_full | Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_fullStr | Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_full_unstemmed | Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_short | Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 |
title_sort | current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on cns barrier congress london, uk, 2017 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674735/ https://www.ncbi.nlm.nih.gov/pubmed/29110676 http://dx.doi.org/10.1186/s12987-017-0079-9 |
work_keys_str_mv | AT greenwoodjohn currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT hammarlundudenaesmargareta currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT joneshazelc currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT stittalanw currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT vandenbroukeroosmarijne currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT romeroignacioa currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT campbellmatthew currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT frickergert currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT brodinbirger currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT manningaheiko currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT gaillardpieterj currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT schwaningermarkus currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT webstercarl currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT wicherkrzysztofb currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 AT khrestchatiskymichel currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017 |